Tina Parkner

834 total citations
46 papers, 538 citations indexed

About

Tina Parkner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, Tina Parkner has authored 46 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 11 papers in Neurology. Recurrent topics in Tina Parkner's work include Diabetes Management and Research (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (9 papers). Tina Parkner is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Treatment and Management (9 papers). Tina Parkner collaborates with scholars based in Denmark, Switzerland and United Kingdom. Tina Parkner's co-authors include Cindy Soendersoe Knudsen, Claus Vinter Bødker Hviid, Bo Martin Bibby, Holger Jon Møller, Søren Nielsen, Lars Peter Sørensen, Jens Sandahl Christiansen, Bente Klarlund Pedersen, Christian P. Fischer and Anders R. Nielsen and has published in prestigious journals such as Diabetes Care, Diabetologia and Clinica Chimica Acta.

In The Last Decade

Tina Parkner

40 papers receiving 529 citations

Peers

Tina Parkner
Xueli Cai China
John Cardinal Australia
Ganesh Chauhan India
M. Lundqvist Sweden
Engın Güney Türkiye
M. Yanagisawa Japan
Ximei Shen China
A A Khaleeli United Kingdom
Min Young Chung South Korea
Xueli Cai China
Tina Parkner
Citations per year, relative to Tina Parkner Tina Parkner (= 1×) peers Xueli Cai

Countries citing papers authored by Tina Parkner

Since Specialization
Citations

This map shows the geographic impact of Tina Parkner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Parkner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Parkner more than expected).

Fields of papers citing papers by Tina Parkner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina Parkner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Parkner. The network helps show where Tina Parkner may publish in the future.

Co-authorship network of co-authors of Tina Parkner

This figure shows the co-authorship network connecting the top 25 collaborators of Tina Parkner. A scholar is included among the top collaborators of Tina Parkner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Parkner. Tina Parkner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Andersen, Signe T., Tina Parkner, Claus Vinter Bødker Hviid, et al.. (2025). Serum Neurofilament Light Chain and Structural and Functional Nerve Fiber Loss in Painful and Painless Diabetic Polyneuropathy. Diabetes Research and Clinical Practice. 223. 112098–112098.
3.
Knudsen, Cindy Soendersoe, et al.. (2025). Neurofilament light chain – Can it be measured in urine?. Clinica Chimica Acta. 569. 120163–120163.
4.
5.
Knudsen, Cindy Soendersoe, Tina Parkner, Elke Hoffmann, Anders Abildgaard, & Eva Greibe. (2023). Reference intervals and stability of haptocorrin and holotranscobalamin in Danish children and elderly. Clinica Chimica Acta. 546. 117394–117394. 4 indexed citations
6.
Andersen, Signe T., Tina Parkner, Claus Vinter Bødker Hviid, et al.. (2023). Serum neurofilament light chain – A potential biomarker for polyneuropathy in type 2 diabetes?. Diabetes Research and Clinical Practice. 205. 110988–110988. 9 indexed citations
7.
Abildgaard, Anders, Tina Parkner, Cindy Soendersoe Knudsen, Hanne Gottrup, & Henriette Klit. (2022). Diagnostic Cut-offs for CSF β-amyloid and tau proteins in a Danish dementia clinic. Clinica Chimica Acta. 539. 244–249. 5 indexed citations
8.
Winther‐Larsen, Anne, et al.. (2019). Reference limits for GAD65 and IA-2 autoantibodies by chemiluminescence immunoassay in Northern European adults and children. Scandinavian Journal of Clinical and Laboratory Investigation. 79(1-2). 123–125. 1 indexed citations
9.
Grode, Louise Bang, Tina Parkner, Inge Agerholm, et al.. (2019). Diagnostic Accuracy of a Point-of-Care Test for Celiac Disease Antibody Screening among Infertile Patients. Inflammatory Intestinal Diseases. 4(3). 123–130. 7 indexed citations
10.
Grode, Louise Bang, Inge Agerholm, Peter Humaidan, et al.. (2018). Unrecognised coeliac disease among men and women undergoing fertility treatment: A screening study. United European Gastroenterology Journal. 6(10). 1477–1484. 9 indexed citations
11.
Parkner, Tina, et al.. (2015). Interaction Between Exogenous Insulin, Endogenous Insulin, and Glucose in Type 2 Diabetes Patients. Diabetes Technology & Therapeutics. 17(5). 335–342. 2 indexed citations
12.
Sørensen, Lars Peter, Tina Parkner, Esben Søndergaard, et al.. (2015). Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus. Endocrine Connections. 4(1). 27–36. 25 indexed citations
13.
Parkner, Tina, et al.. (2013). Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients. Growth Hormone & IGF Research. 23(6). 256–260. 6 indexed citations
14.
Ma, Zhulin, Tina Parkner, Jan Frystyk, et al.. (2012). A Comparison of Pharmacokinetics and Pharmacodynamics of Insulin Aspart, Biphasic Insulin Aspart 70, Biphasic Insulin Aspart 50, and Human Insulin: A Randomized, Quadruple Crossover Study. Diabetes Technology & Therapeutics. 14(7). 589–595. 11 indexed citations
15.
Ma, Zhulin, Tina Parkner, Jens Sandahl Christiansen, & Torben Laursen. (2012). IDegAsp: a novel soluble insulin analogs combination. Expert Opinion on Biological Therapy. 12(11). 1533–1540. 14 indexed citations
16.
Parkner, Tina, Lars Peter Sørensen, Anders R. Nielsen, et al.. (2012). Soluble CD163: a biomarker linking macrophages and insulin resistance. Diabetologia. 55(6). 1856–1862. 88 indexed citations
17.
Petersen, Steffen B., Jonas Kildegaard, F. S. Nielsen, et al.. (2009). Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus. Diabetes Obesity and Metabolism. 12(4). 334–340. 5 indexed citations
18.
Parkner, Tina, Stig Dyrskog, Tomas Laursen, et al.. (2009). Obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 12(5). 414–420. 4 indexed citations
19.
Parkner, Tina, Tomas Laursen, Esben Thyssen Vestergaard, et al.. (2008). Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long‐acting insulin in Type 2 diabetes1. Diabetic Medicine. 25(5). 585–591. 20 indexed citations
20.
Parkner, Tina, et al.. (2007). Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes. Diabetes Obesity and Metabolism. 10(7). 556–563. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueli Cai Breakdown of academic impact, for papers by John Cardinal Breakdown of academic impact, for papers by Ganesh Chauhan Breakdown of academic impact, for papers by M. Lundqvist Breakdown of academic impact, for papers by Engın Güney Breakdown of academic impact, for papers by M. Yanagisawa Breakdown of academic impact, for papers by Ximei Shen Breakdown of academic impact, for papers by A A Khaleeli Breakdown of academic impact, for papers by Min Young Chung
Rankless by CCL
2026